Company: TGNT
Filing Date: 2025-04-07
Form Type: 10-K
Source: 0001477932-25-002496
Chunk: 426

Company: Totaligent, Inc.
Filing Date: 2025-04-07
Form: 10-K
Item: Item 5
Chunk 426
---
2023 Balances at beginning of period $149,182  $161,565 Issuances:        Embedded derivatives  -   26,376 Conversions/extinguishments        Changes in fair value inputs and assumptions reflected in income  8,873   (38,759 )Balances at end of period $158,055  $149,182 

 F-16Table of Contents

7. Commitments and contingencies  Legal contingencies  The Company may be subject to legal proceedings from time to time as part of its business activities. As of December 31, 2024, the Company was not subject to any threatened or pending legal actions or claims. Significant agreements and contracts None

8. Equity     Preferred Stock The Company has authorized a total of 10,000,000 shares of preferred stock, par value $0.01 per share. The Company has 1,000,000 shares authorized for Series D Preferred Stock. As of December 31, 2024 and 2023, the Company had issued 713,750 and 603,750 shares of Series D Convertible Preferred Stock, respectively. The Company’s Board of Directors has the authority to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding. Common Stock As of December 31, 2024 and 2023, respectively, the Company had authorized 500,000,000 shares of its common stock, par value $0.001 per share. As of December 31, 2024 and 2023, the Company had 211,101,313 shares of common stock issued, and 172,913,813 of common stock outstanding. Shares to be issued As of December 31, 2024 and 2023,